Proficio Capital Partners LLC purchased a new stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 185,802 shares of the company’s stock, valued at approximately $186,000.
Several other hedge funds and other institutional investors also recently modified their holdings of the business. Swedbank AB raised its position in Colgate-Palmolive by 1.4% during the third quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock valued at $306,246,000 after purchasing an additional 40,324 shares in the last quarter. Ashton Thomas Securities LLC bought a new position in shares of Colgate-Palmolive during the 3rd quarter valued at about $109,000. Apollon Wealth Management LLC raised its holdings in shares of Colgate-Palmolive by 3.9% during the 3rd quarter. Apollon Wealth Management LLC now owns 22,571 shares of the company’s stock valued at $2,343,000 after buying an additional 839 shares in the last quarter. Harbour Investments Inc. lifted its position in Colgate-Palmolive by 7.1% in the 3rd quarter. Harbour Investments Inc. now owns 9,836 shares of the company’s stock worth $1,021,000 after buying an additional 650 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. boosted its stake in Colgate-Palmolive by 1.2% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,989,776 shares of the company’s stock worth $206,559,000 after buying an additional 23,099 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research analysts have commented on CL shares. Royal Bank of Canada reissued a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. TD Cowen lowered their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Finally, Barclays lowered their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $101.61.
Colgate-Palmolive Stock Down 3.6 %
Shares of Colgate-Palmolive stock opened at $90.71 on Thursday. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The company has a market cap of $73.61 billion, a P/E ratio of 25.77, a PEG ratio of 4.20 and a beta of 0.40. The company’s fifty day simple moving average is $89.03 and its two-hundred day simple moving average is $94.96.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the company earned $0.87 EPS. Research analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- About the Markup Calculator
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- What is the Euro STOXX 50 Index?
- Why Energy Transfer Belongs on Your Watchlist
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.